We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$507M
AUM Growth
-$160M
Cap. Flow
-$109M
Cap. Flow %
-21.48%
Top 10 Hldgs %
40.1%
Holding
696
New
71
Increased
159
Reduced
213
Closed
50

Sector Composition

Rank Sector Weight
1 Financials 12.36%
2 Technology 8.28%
3 Consumer Staples 6.89%
4 Consumer Discretionary 6.15%
5 Healthcare 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOCA
676
DELISTED
Endesa Americas S.A.
EOCA
-1
Closed -$14
CTIC
677
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
0
SCTY
678
DELISTED
SolarCity Corporation
SCTY
-19,407
Closed -$380K
DO
679
DELISTED
Diamond Offshore Drilling
DO
-2,709
Closed -$47.7K

Similar funds

Exane Derivatives's Q4 2016 Portfolio in Review

As of Q4 2016, Exane Derivatives held 696 positions worth $507M, down 24% from $666M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Exane Derivatives withdrew a net $109M in Q4 2016, closing 50 positions and reducing 213 holdings. Its most notable exit was Vale, an estimated $8.59M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 6.6% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Exane Derivatives opened a new position in Ingredion worth $4.09M.

  • Exane Derivatives's largest Q4 2016 buy was Ingredion: 32,719 shares worth $4.09M.
  • Exane Derivatives added most to iShares MSCI Emerging Markets ETF in Q4 2016, an estimated $11.9M increase.
  • Exane Derivatives's biggest Q4 2016 reduction was iShares MSCI Thailand ETF, cutting an estimated $12.4M.
  • Exane Derivatives fully exited Vale in Q4 2016, selling an estimated $8.59M.
  • Exane Derivatives's ten largest holdings make up 40% of its $507M portfolio in Q4 2016.
  • Exane Derivatives opened 71 new positions and closed 50 in Q4 2016.
  • Exane Derivatives's portfolio value fell 24% quarter-over-quarter to $507M.

Based on Exane Derivatives's 13F filing for Q4 2016, filed 27 Jan 2017.